Immunology

Research Field Cancer

Chasing Checkpoints

| Frédéric Triebel

Therapeutic modulation of checkpoint inhibitors is bringing new treatment to cancer patients

Outside the Lab Immunology

Cold War

| James Strachan

A vaccine against the common cold has long eluded us, but now researchers are on its track

Research Field Immunology

STAR2: A New Hope

| William Aryitey

New hope in the battle against the dark side of transplantation

Research Field Immunology

The Second Coming of Daclizumab

| Thomas Waldmann

Dropped as an anti-rejection drug, daclizumab is back with a new indication in MS

Research Field Immunology

Mucky Pups

| William Aryitey

New findings have revealed that “dirty” mice can actually recapitulate the human adult immune system better than lab mice

Research Field Microbiology

Medicine Meets the Microbiome

| Karim Dabbagh

The moment a baby enters the world – even before its first breath – the tiny body receives a massive infusion of bacteria, viruses and fungi.

Disease Area Immunology

Image of the Month

| Charlotte Barker

How do birds transmit potentially fatal fungal infection to humans without being infected themselves?

Disease Area Immunology

Image of the Month

| Charlotte Barker

On each side of the brain stem, a florescent green marker illuminates the two networks of 200 neurons that control the sighing reflex

Research Field Cancer

Unlocking Checkpoint Inhibition

| Eric Rubin, David Matthews

Like many drugs today, pembrolizumab (Keytruda) was the result of a group effort. Here, we catch up with two scientists who shaped the destiny of the biotherapeutic at very different stages in its development.

Tools & Techniques Cancer

PD-1 on the Brain

| William Aryitey

Revolutionary cancer immunotherapies appear to alleviate Alzheimer’s symptoms in mice

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register